![Neena Patil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 12 M $ al 30/06/2026
Neena M.
Patil is currently Independent Director at Teleflex, Inc. since 2022.
Ms. Patil is Director at mothers2mothers.
Ms. Patil is Director at Princeton Medical Center Foundation since 2015.
Ms. Patil is Chief Legal Officer & Executive Vice President at Jazz Pharmaceuticals, Inc. since 2019.
Ms. Patil is Chief Legal Officer & Executive Vice President at Jazz Pharmaceuticals Plc since 2022.
Formerly, Ms. Patil was Secretary, General Counsel & Senior Vice President at Abeona Therapeutics, Inc. from 2018 to 2019.
Ms. Patil was VP-Legal Affairs & Associate General Counsel at Novo Nordisk, Inc. from 2008 to 2016.
Education includes a graduate degree from the University of Michigan conferred in 1999 and an undergraduate degree from Georgetown University conferred in 1996.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2026 | 48.871 ( 0,08 % ) | 12 M $ | 30/06/2026 | |
TELEFLEX INCORPORATED 0,01 % | 15/05/2026 | 3.716 ( 0,01 % ) | 471 040 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Consejero General | 01/07/2019 |
| TELEFLEX INCORPORATED | Director/Miembro de la Junta | 29/04/2022 |
Princeton Medical Center Foundation | Director/Miembro de la Junta | 01/01/2015 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Consejero General | 01/07/2019 |
mothers2mothers
 mothers2mothers Miscellaneous Commercial ServicesCommercial Services Operates an non-governmental organization that prevents mother to child transmission of human immunodeficiency virus | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Consejero General | 01/07/2019 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Consejero General | 01/10/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Teleflex, Inc.
 Teleflex, Inc. Medical SpecialtiesHealth Technology Provides medical devices for critical care, urology and surgery | Health Technology |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
mothers2mothers
mothers2mothers Miscellaneous Commercial ServicesCommercial Services Operates an non-governmental organization that prevents mother to child transmission of human immunodeficiency virus | Commercial Services |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Princeton Medical Center Foundation |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
